Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anri Azuma"'
Autor:
Kazuto Nakamura, Soichi Yamashita, Keiko Kigure, Toshio Nishimura, Ikuro Ito, Anri Azuma, Kohshiro Nakao, Ken Ando, Tatsuya Kanuma
Publikováno v:
BMC Women's Health, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background In Japan, 8000 women were newly diagnosed with cervical cancer in 2018. The healthcare insurance policy in Japan allows physicians to utilize vaginal volt cytology tests and serum biomarker measurement at every visit and imaging a
Externí odkaz:
https://doaj.org/article/2abb5d85cc234af3bb2df263732d06f5
Autor:
Kazuto Nakamura, Yoshikazu Kitahara, Soichi Yamashita, Keiko Kigure, Ikuro Ito, Toshio Nishimura, Anri Azuma, Tatsuya Kanuma
Publikováno v:
BMC Women's Health, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background In Japan, 17,000 women are newly diagnosed with endometrial cancer in 2018. The healthcare insurance policy in Japan provides more intensive patient surveillance compared with the United States and European countries. The aim of t
Externí odkaz:
https://doaj.org/article/fc5c42fbff8f49a7add7e6376778d9fe
Autor:
Yusuke Kajimoto, Kazunori Honda, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takashi Shibutani, Shoji Nagao, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Keiichi Fujiwara, Ataru Igarashi
Publikováno v:
International Journal of Clinical Oncology. 28:454-467
Autor:
Azusa Kobayashi, Koshiro Nakao, Hisano Takakuwa, Amane Shuto, Anri Azuma, Tae Oike, Sadatomo Ikeda, Takashi Hirakawa, Akira Iwase
Publikováno v:
JAPANESE JOURNAL OF GYNECOLOGIC AND OBSTETRIC ENDOSCOPY. 38:209-213
Autor:
Yusuke Kajimoto, Takashi Shibutani, Shoji Nagao, Satoshi Yamaguchi, Shiro Suzuki, Masahiko Mori, Hirofumi Tsubouchi, Kohshiro Nakao, Anri Azuma, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Kazunori Honda, Ataru Igarashi
Publikováno v:
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.
ObjectiveFinancial toxicity is a financial burden of cancer care itself, which leads to worse quality of life and higher mortality and is considered an adverse effect. The COmprehensive Score for financial Toxicity (COST) tool is a patient-reported o
Autor:
Kazunori Honda, Hirofumi Tsubouchi, Masahiko Mori, Shiro Suzuki, Kohshiro Nakao, Anri Azuma, Shoji Nagao, Takashi Shibutani, Takahiro Koyanagi, Izumi Kohara, Shuko Tamaki, Midori Yabuki, Lida Teng, Yusuke Kajimoto, Ataru Igarashi
Publikováno v:
Annals of Oncology. 33:S477